GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employees Genetic Technologies and 'Wellworks for You' sign B2B sales and marketing deal covering 750 employer groups and 2 million U.S. employees

GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year

GTG to pilot GeneType in Breast Screen centers across the U.S. Genetic Technologies to pilot GeneType in Breast Screen centers across the U.S.

Transformational Pathway to US Payer System; Attributing US$1.4 Billion Health and Economic Benefit from geneType Breast Cancer Risk Assessment Test MELBOURNE, Australia, June 16, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and...

US Patent Office Grants Key Risk Test Patent Issuance of US Patent No: US 10,683,549, Methods for assessing risk of developing breast cancer.Filed provisional patent for its COVID-19 Severity Risk Test, 2020901739 – Methods of assessing risk...